Our lab studies the molecular mechanisms of Mtb pathogenesis and its different host immune evasion mechanisms and attempts new targeted therapy for tuberculosis
Congratulations to Prof. Avinash Sonawane for being awarded National Bio Entrepreneurship Award 2021 in Drug Development and Health Care category. @EduMinOfIndia
@soumohanty1987 @J_A_C_S@LabMalkoch@karolinskainst@KTHuniversity A big congratulations to @soumohanty1987 and everyone involved in the study. Significant work with strong clinical relevance in future against many drug resistance bacteria.
We are happy that a cost effective asparaginase (enzyme used for the treatment), MASPAR developed by us using protein engineering approach to treat acute lymphoblastic leukemia is ready to enter phase-1 clinical trial. @IITIOfficial@ACTREC_TMC
https://t.co/31hT3zTFWX
Our recent study highlights the role of Mtb EsxL in regulation of TNF-α secretion via TLR2 mediated activation of NF-κB and MAPK signalling in murine macrophages. @ImmunologyNews @IITIOfficial @BSBE_IIT_Indore
https://t.co/9PDVmSxfZW
Happy to share our recent work on dissecting the effect of metformin on CD8+ T cells, towards our understanding of its anti-TB activity. Great collaboration with @EvNewell1, Hardy Kornfeld & others 🙂
https://t.co/fsIPK1VyIK
Our research work on TRPV4 as a host directed therapeutics for the treatment of Tuberculosis has been covered by scientific magazine @DrugTargetRev .
https://t.co/ImEZRVPxjq
Differential roles of the calcium ion channel TRPV4 in host responses to Mycobacterium tuberculosis early and late in infection https://t.co/pLH3Of621W
@VivekRaoigib@IGIBSocial Host directed therapy and Re-Purposing drugs are indeed the way to move forward in dealing Tuberculosis. Good work by the authors.
Here is our latest article in collaboration with Schaible Group @FZBorstel entitled "Differential roles of the calcium ion channel TRPV4 in host responses to Mycobacterium tuberculosis early and late in infection". @iScience_CP@IITIOfficial
https://t.co/Yl3mjLiarX